Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery

Contributed by: Business Wire

Logo

Tags

Biotechnology

Technology

Professional Services

Health

Pharmaceutical

Venture Capital

Health Technology

Research

Artificial Intelligence

Science

Finance

Financing

More Like This

Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic programs into the clinic

PR Newswire associated0

AI Governance Startup DAIKI GmbH Raises €1.5 Million in Seed Funding

Unlocking the Power of Large Language Models: From Neural Network Basics to Biopharma Industry Transformation

Hyku Biosciences Launches With $56M to Advance its Covalent Medicines Platform to Expand the Boundaries of Drug Discovery

PR Newswire associated0

GEN AI ANALYTICS PROVIDER, RELIANT AI, LAUNCHES WITH $11.3M IN SEED FUNDING

PR Newswire associated0

Araceli Biosciences Closes $11.2M Seed Financing to Change the Pace of Drug Discovery

PR Newswire associated0

Merck Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis

Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395